FLC
RVNC

Fifth Lane Capital’s Revance Therapeutics, Inc. RVNC Stock Holding History

Fifth Lane Capital’s Portfolio RVNC Stock Details RVNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-30,000
Closed -$156K – 63
2024
Q3 		$156K Buy
+30,000
New +$156K 0.39% 28